Discernment of rare alleles in circulating free DNA (cfDNA) may be a useful method for detecting the presence of new or recurring cancer long before it becomes symptomatic and, perhaps, when it is more treatable. Unfortunately the false-positive rate of current methods reduce specificity to an unacceptable level at allele frequencies of less than ~0.5%.
Tissue and cfDNA Rare Alleles How Low Can We Go
Video Apr 28, 2015
SPEDs: Self-powered, Paper-based Electrochemical DevicesVideo
The self-powered, paper-based electrochemical devices, or SPEDs, are designed for sensitive diagnostics at the “point-of-care,” or when care is delivered to patients, in regions where the public has limited access to resources or sophisticated medical equipment.WATCH NOW
Understand your lab turnaround time with STARLIMS Advanced Analytics dashboardsVideo
Be proactive: make data-driven decisions by being in control of your lab turnaround time.